Dante Kemp, Director, MSc Biostatistics
Dante specialises in the development of economic models and the provision of statistical analyses. He manages health economics projects such as reimbursement submissions, evidence-based literature reviews, retrospective and prospective collection of outcome and resource data, and pricing analyses. He also conducts statistical analyses including writing of statistical analysis plans, data management, development of statistical models, clinical trial design, and analysis of clinical trial data. Dante specializes in preparing PBAC and MSAC submissions.
Dante has more than fifteen years’ experience working in health economics and biostatistics. Dante was a senior HEOR manager in Labcorp’s Market Access Services group and a statistician at John Wlodarczyk Consulting Services. Dante has supported reimbursement activities in a dozen countries (North America, Europe and Asia Pacific regions). He developed the global economic models for two recent treatments in pulmonary arterial hypertension and supported the reimbursement submissions internationally. As a statistician, Dante planned and conducted the analysis of two clinical trials in pain management and numerous database studies.
Dante holds a Master’s of Science in Biostatistics from the New Jersey Institute of Technology, and a Bachelor of Science in Biochemistry from Rutger’s University.